BRGXOTCServices-Computer Programming, Data Processing, Etc.Fiscal year ends December 31
BIOREGENX, INC.
Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on May 20, 2026
$0.00+0.00 (0.00%)
Close on Oct 16, 2026
- Market cap
- $3.88M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$0.0059 (−59.60%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
BIOREGENX, INC. saw revenue fall 23.4% to $1.77M over the twelve months to Mar 31, 2026. Free cash flow was $29.92K.
Revenue
$1.77M
-23.4% vs. a year earlier
Operating income
-$1.10M
TTM Q1 2026
Free cash flow
$29.92K
FY2025
EPS, diluted
$0.00
TTM Q1 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Mar 31, 2026
Valuation
- Market cap
- $3.88M
- P/E ratio
- –
- Price to sales
- 2.20
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- 0.77%
Fundamentals
- Revenue
- $1.77M
- Net income
- -$1.30M
- EPS, diluted
- $0.00
- Free cash flow
- $29.92K
- Book value per share
- -$0.00
- Diluted shares
- 969M
Six years at a glance
Fiscal years 2020 to 2025 and trailing twelve months, USD
Revenue
$1.77M-23.4% YoY
Gross profit
$1.45M-13.9% YoY
Operating income
-$1.10M
Net income
-$1.30M
EPS, diluted
$0.00
Free cash flow
–
Reported periodTrailing twelve months